PATENT CLAIM ANALYSIS

Application Number: 15879826
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["544", "323000"]

Abstract:
The various examples presented herein are directed to compounds of the Formula: wherein R 1 -R 5  are defined herein, and uses of such compounds to, among other things, inhibit an immune response in a subject.

Claim (Index 1):
A compound of the Formula (II): or a pharmaceutically acceptable salt, polymorph, prodrug, solvate or clathrate thereof, wherein: R 1  and R 2  are each, independently, H, (C 1 -C 20 )-alkyl or (C 6 -C 20 )-aryl-(C 1 -C 20 )-alkyl; R 3  is (C 1 -C 20 )-alkyl or (C 6 -C 12 )-aryl; R 4  is (C 1 -C 20 )-alkyl, (C 1 -C 20 )-alkynyl, (C 6 -C 20 )-aryl-(C 1-20 )-alky, (C 6 -C 20 )-aryl-(C 2-20 )-alkynyl, (C 6 -C 20 )-cycloalkyl-(C 1-20 )-alkyl, (C 2-20 )-alkynyl-NR 6 R 7  or (C 1-20 )-alkyl-NR 6 R 7 , wherein R 6  and R 7  are each, independently, H, (C 1-20 )-alkyl, (C 6 -C 20 )-aryl-(C 1-20 )-alkyl or, R 6  and R 7 , together with the nitrogen to which they are attached from a (C 2 -C 20 )-heterocyclyl group; and R 5  is \u2014NR 8 R 9 , wherein R 8  and R 9  are each, independently, H, (C 1-20 )-alkyl or (C 6-12 )-aryl-(C 1-20 )-alkyl.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.20588
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13509646', '13939232', '14670421', '15359871', '12728153']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7492647768007041
- 35 USC 102 Novelty (BERT): 0.5019340562264583
- Combined Prediction Score: 0.7245317047432795
- Mean Citation Score: 214.498996
- Max Citation Score: 218.93631
- Similarity Product: 147.1428805728936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test